VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30074699 | HIV | ENSG00000142920.18 | protein_coding | AZIN2 | No | No | 113451 | Q96A70 |
TVIS30074700 | HIV | ENSG00000142920.18 | protein_coding | AZIN2 | No | No | 113451 | Q96A70 |
TVIS30074701 | HIV | ENSG00000142920.18 | protein_coding | AZIN2 | No | No | 113451 | Q96A70 |
TVIS30023087 | HIV | ENSG00000142920.18 | protein_coding | AZIN2 | No | No | 113451 | Q96A70 |
TVIS30023088 | HIV | ENSG00000142920.18 | protein_coding | AZIN2 | No | No | 113451 | Q96A70 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | AZIN2 |
---|---|
DrugBank ID | DB00125 |
Drug Name | Arginine |
Target ID | BE0000448 |
UniProt ID | Q96A70 |
Regulation Type | |
PubMed IDs | 16703907; 17025265; 17287563; 17653850 |
Citations | Kotil K, Kuscuoglu U, Kirali M, Uzun H, Akcetin M, Bilge T: Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial. J Neurosurg Spine. 2006 May;4(5):392-9.@@Regunathan S: Agmatine: biological role and therapeutic potentials in morphine analgesia and dependence. AAPS J. 2006 Jul 21;8(3):E479-84.@@Yang HQ, Gao HJ: [Physiological function of arginine and its metabolites in plants]. Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao. 2007 Feb;33(1):1-8.@@Wu N, Su RB, Li J: Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence. Cell Mol Neurobiol. 2008 Aug;28(5):629-41. Epub 2007 Jul 25. |
Groups | Investigational; Nutraceutical |
Direct Classification | L-alpha-amino acids |
SMILES | N[C@@H](CCCNC(N)=N)C(O)=O |
Pathways | Citrullinemia Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Argininemia; Hyperornithinemia with Gyrate Atrophy (HOGA); Canavan Disease; Hypoacetylaspartia; Hyperprolinemia Type II; 3-Phosphoglycerate Dehydrogenase Deficiency; Non-Ketotic Hyperglycinemia; Argininosuccinic Aciduria; L-Arginine:Glycine Amidinotransferase Deficiency; Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Glycine and Serine Metabolism; Hyperglycinemia, Non-Ketotic; Dimethylglycine Dehydrogenase Deficiency; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Carbamoyl Phosphate Synthetase Deficiency; Ornithine Aminotransferase Deficiency (OAT Deficiency); Hyperprolinemia Type I; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Aspartate Metabolism; Nitric Oxide Signaling Pathway; Arginine and Proline Metabolism; Ornithine Transcarbamylase Deficiency (OTC Deficiency); Prolinemia Type II; Urea Cycle; Sarcosinemia |
PharmGKB | PA448478 |
ChEMBL | CHEMBL1485 |